U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
TILVESTAMAB
INN  
Official Name English
BGB149
Code English
Tilvestamab [WHO-DD]
Common Name English
IMMUNOGLOBULIN IGG1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE AXL) (HUMAN-MUS MUSCULUS MONOCLONAL BGB149 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BGB149 .KAPPA.-CHAIN, DIMER
Common Name English
tilvestamab [INN]
Common Name English
BGB-149
Code English
Code System Code Type Description
NCI_THESAURUS
C175866
Created by admin on Sat Dec 16 15:00:58 GMT 2023 , Edited by admin on Sat Dec 16 15:00:58 GMT 2023
PRIMARY
INN
11122
Created by admin on Sat Dec 16 15:00:58 GMT 2023 , Edited by admin on Sat Dec 16 15:00:58 GMT 2023
PRIMARY
FDA UNII
IZK2TH7X5M
Created by admin on Sat Dec 16 15:00:58 GMT 2023 , Edited by admin on Sat Dec 16 15:00:58 GMT 2023
PRIMARY
CAS
2226775-26-2
Created by admin on Sat Dec 16 15:00:58 GMT 2023 , Edited by admin on Sat Dec 16 15:00:58 GMT 2023
PRIMARY
ACTIVE MOIETY
TILVESTAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966